9 /l for leukocyte count. At a median follow-up of 38 months, eight deaths, one leukemic transformation and two post-PV myelofibrosis were documented. Arterial and venous thrombosis occurred in 10 (13%) and four (5%) patients at diagnosis and in 15 (19.5%) and four (5%) patients during follow-up, respectively.
Linear regression analysis for continuous variables revealed that JAK2V617F allele burden correlated directly with leukocyte count (Po0.0001) but not with hemoglobin level (P ¼ 0.39), platelet count (P ¼ 0.85), or age (P ¼ 0.85). Similarly, allele burden was not affected by gender (P ¼ 0.9). Allele burden (considered as a continuous variable) was significantly higher in the presence of pruritus (P ¼ 0.003) or microvascular symptoms (P ¼ 0.03) but not palpable splenomegaly (P ¼ 0.89) or cytotoxic therapy during follow-up (n ¼ 57 versus 20 patients not receiving such therapy; P ¼ 0.3). Mutant allele burden was similar between the 14 patients who presented with major thrombosis (both arterial and venous) and the 63 patients who did not (P ¼ 0.32); similarly, allele burden was not significantly different in those patients who developed major thrombosis during follow-up (n ¼ 19) compared to those who did not (n ¼ 58; P ¼ 0.95). The results did not change when arterial thrombosis (P ¼ 0.38 at diagnosis and 0.75 during follow-up) was analyzed separately from venous thrombosis (P ¼ 0.51 at diagnosis and 0.49 during follow-up). The above-mentioned results regarding clinical correlations of bone marrow JAK2V617F allele burden remained the same, for the most part, when allele burden was treated as a categorical variable with either two groups above and below the median value or three groups with allele burdens upto 25% (n ¼ 55), between 25 and 50% (n ¼ 10) and above 50% (n ¼ 12), respectively. The only different outcome was the loss of significant correlation involving microvascular symptoms and pruritus when allele burden was categorized into three groups. Finally, the number of events in terms of death, leukemic transformation, or development of post-PV myelofibrosis was too small to allow valid statistical comparisons of survival or disease transformation.
Taken together, the findings from the current study are underwhelming in terms of clinical relevance of bone marrow JAK2V617F allele burden in PV. The strongest and most consistent correlation was leukocytosis, an observation that warrants the inclusion of leukocyte count as a covariate in any statistical analysis of prognostic relevance that includes JAK2V617F allele burden. This result is pertinent to the recent emphasis on the prognostic relevance of leukocytosis in both PV and ET. 7 Our findings also underline the potential confounding effect of sample accrual time on result interpretation. Finally, we underscore the fact that the current study utilized DNA from archived bone marrow and should not be compared with other studies that have used either DNA 2 Several studies have shown that selected aspects of a history of infection and vaccination may be related to the risk of LN. [1] [2] [3] [4] [5] The results are heterogeneous, varying with the type of infectious disease considered and with the histologic analysis of NHL as a whole or by subtype. A history of infectious mononucleosis was shown to be positively associated with NHL, 1,2 but negatively associated with follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLCL), in the only histologic subtype analysis, which was conducted by Holly et al. 4 A medical history of herpes (labial) or hepatitis has been reported to be negatively related to NHL considered by subtype (DLCL and FL), but analyses conducted on all NHL generated nonsignificant results or a positive association. 2, 3 Few results for bacterial infections are available: scarlet fever, pneumonia, pyelonephritis, tuberculosis and chronic infection have been reported to constitute an NHL risk. [1] [2] [3] 5 However, those findings were based on single-studies, or non-significant associations, or were not confirmed by histologic subtype analysis. 4 Foreign travel does not seem to be associated with NHL. 4 The results for a history of malaria are contradictory. 3, 5 Immunization history also modulates immune regulation. In two case-control studies, 3, 4 there was a consistent pattern of decreased NHL risk, by disease subtype, associated with vaccinal history, except for BCG vaccination. Neither of the published studies included French data.
Between 2000 and 2004, we conducted a multicentre hospital-based case-control study (Bordeaux, Brest, Caen, Lille, Nantes and Toulouse) including 824 cases and 752 controls. Eligible case were 18-75 years old, hospitalized for a recent diagnosis of non-Hodgkin's lymphoma (n ¼ 399), HL (n ¼ 149), MM (n ¼ 108) or lymphoproliferative syndromes (LPS; n ¼ 168), including CLL and hairy cell leukaemia. Patients infected by HIV or treated by immunosuppressive drug were not eligible. Controls were hospitalized for any cause except a cancer, an accident or a disease directly related to occupation, tobacco or alcohol consumption and individually matched with cases by centre, gender, age (73 years) and residential area. Face-to-face interviews were performed by trained interviewers using a standardized questionnaire on different topics including sociodemographic characteristics and personal medical history (occurrence of viral, bacterial diseases, common infection in childhood, chronic infection, tropical or parasitic diseases occurred during foreign travels). All the analyses were conducted using STATA software (version 8.2). The paired matching was broken for most analyses to gain power, using more controls per cases. Odds ratios (OR) were estimated using unconditional logistic regression and adjusted for matching variables. Polytomous logistic models were used to estimate OR jointly for the main NHL subgroups.
Age and sex were similarly distributed between cases and controls, all cases taken together. All strata comprised at least one control by case. Cases and controls were comparable according to their socio-professional categories and educational level, except for HL cases who were less often factory workers than controls. Table 1 reports the association between history of infections based on patient's interview and large classes of LN. Infectious mononucleosis was significantly associated with HL (OR ¼ 2.6 [1.3-5.3]), and the association was stronger for men (OR ¼ 4.7 [1.7-13.1]) than women (OR ¼ 1.4 [0.5-3.9]). There was no particular relationship with the age of mononucleosis occurrence. Only two cases and two controls had declared having had a mononucleosis after the age of 30 years. None of the LN was related with a history of herpes (cold sore or genital herpes) or shingles. ORs associated with a reported history of hepatitis of any type were slightly lower than the unit. No relationship was Table 1 Relationship between history of infectious diseases and lymphoid neoplasms LPS NHL HL MM Ca Co OR 95% CI P Ca Co OR 95% CI P Ca Co OR 95% CI P Ca Co OR 95% CI P We observed an inverse relationship between vaccination against influenza and LPS, NHL and MM (Table 2) Adjustment for socioprofessional categories and educational level did not change any of the results. Neither did the results change when conditional nor polytomous regression models were used to test the robustness of the observations. Results also remained stable when we repeated the analyses excluding any centres or any categories of causes of admission of controls to appreciate their weight in the estimations. Furthermore, the relationships between influenza immunization and LPS, NHL and MM were reinforced when the analyses were performed excluding immunizations received before the last 5 years before , respectively. Conversely, no association was observed when considering only the immunization received during the last 5 years. Finally, to avoid residual confounding by age, we repeated the analyses using narrower categories of age (3 years) to adjust for, and this did not change the results.
Various points of this study can be discussed: all were incident cases, which were systematically contacted by the interviewers and only 48 (5.5%) refused the interview. Except for LPS whose good prognosis allowed that the interview could take place 1 year after the diagnosis, they were contacted early after the diagnosis to avoid selection on survival. Ninety per cent of the cases were diagnosed within 6 months. There is no obvious reason for patient's selection being related to vaccine status or past infectious disease. Besides, such selection would unlikely affect similarly all centres, and we checked by sensitivity analysis that the results were not modified by oneby-one exclusion of each centre. Cases were classified after pathologist's ascertainment according to the WHO classification. Subgroup analysis was performed whenever allowed by number of cases.
Controls have been mostly selected in orthopaedic and rheumatologic departments. Except for HL cases, who were as expected less often factory workers and had got a higher degree than controls, cases and controls did not differ according to their socioprofessional categories and educational level. To prevent a selection of patients with a lower socioprofessional category than cases and an over-representation of factors of interest in controls, patients admitted for a disease directly related to tobacco smoking, alcohol or occupation were not eligible as controls, although they may have had a history of such disease in the past. None of the causes of admission of the controls is known to be a particular indication for vaccination, or to be related to a particular prevalence of past infectious diseases. In addition, the results were not affected by one-by-one exclusion of each category of cause of admission of the controls. Prevalence of influenza immunization observed in controls was close to that of the French general population, which has been evaluated in 2000 by the national group of influenza Surveillance (http://www.grog.org/documents/2001). The vaccination coverage was estimated of 22% for the general population, close to the prevalence of 25% observed in our control group. The prevalence of vaccination was identical (57%) for subjects aged 65-69 years, and a little lower for those Letters to the Editor aged 70-74 years (60% in the control group versus 66% in the general population). The results remained unchanged when the analysis was restricted to the highest age categories. All our results rely on self-reported medical history and subsequently on patient recall. To minimize recall bias, we used a standardized questionnaire administered in same conditions to cases and controls by trained interviewers. Poor recall precluded investigation of usual infections and immunizations that had taken place during childhood and early adulthood. Recall seemed much better regarding less common diseases such as hepatitis or infectious mononucleosis, and more recent immunizations like that against flu, which data were rarely missing in cases as well as in controls. When we applied a 5-year lag excluding recent immunizations or infections that may have been related to the disease, the results were reinforced.
Influenza vaccination is not a known risk factor of cases or control diseases, making unlikely a voluntary understatement of the exposures by cases or an overstatement by controls. There is no obvious reason, either, for controls to have a better recall of their immunizations than cases. An underestimation of histories of infection for cases and controls is highly probable for many infections which can be forgotten or never known by the subjects themselves. This may be true for immunizations but less likely for repeated immunizations which were usually more recent and may be easier to remember. The relationship observed with the number of injections could be attributed to residual confounding by age, if controls were older than cases, the oldest subjects having received more injections than the youngest. Neither the analysis using strata of 3 years of age instead of 5, nor conditional analysis with individual matching for age 73 years, changed the results. Socioprofessional categories or level of education were considered possible confounding factors, even though these variables were comparable between cases and controls, because they may influence the real prevalence of immunizations and infections as well as the recall and knowledge of personal medical history. These adjustments did not modify any of the results.
The positive association observed between HL and a history of mononucleosis was expected and of the same order of magnitude than that estimated by Hjalgrim et al. 6 (standardized incidence ratio ¼ 2.55 [1.87-3.40] ) from the follow-up of cohorts of mononucleosis patients.
The negative association between influenza immunization and LN has been previously reported by Holly et al. 4 for several subtypes of non-Hodgkin's lymphoma. This study evidenced a significant inverse relationship between DLCL and influenza vaccination (OR ¼ 0.8 [0.6-0.9]). We report that ORs decreased with increasing number of injections of influenza vaccine for NHL and DLCL although non-significant for the latter. We also found a relationship for CLL and MM that had not been described previously, to our knowledge.
Other vaccines against various viral agents have been associated with a decreased risk of NHL: injectable polio vaccine in women, cholera vaccine in men and yellow fever vaccine in both men and women. We also observed OR lower than the unit associated with cholera vaccination for NHL, DLCL and CLL. The associations were not significant but it is noticeable that the prevalence of this vaccine was low in our population (about 10% in our controls versus 25% in the study by Holly et al. 4 ). Conversely, to our knowledge, a positiveassociation between a vaccine against a virus agent and lymphoma (NHL and HL) was only reported once, with oral polio vaccine in an Italian study, 3 between oral polio vaccination and both NHL and HL. Influenza vaccine has been introduced in France mainly after the 1969 pandemic HongKong flu. It can be live, attenuated or inactivated (most often in France) and is recommended in elderly (more than 65 years), for patients with chronic diseases and health care professionals. In the present study, the association with influenza vaccination was stronger for at least five injections and when immunizations had taken place at least 5 years before diagnosis. These two results are linked and we cannot explain the magnitudes of these effects independently. Median of age at first vaccination was 55 years old (20-74 years).
Influenza vaccination by inactivated vaccine induces active immunity by stimulating systemic immune system. After injection, the influenza vaccine components are transported to draining lymph nodes in the armpit, either as free antigen, opsonized or carried by dendritic cells or other antigenpresenting cells. Depending on the formulation, whole or split inactivated influenza vaccine produces an immune response towards Th1 type of cytokines (IL-2 and IFN-g) or Th2 type of cytokines (IL-4, IL-10) respectively. 7 Repeated vaccinations could imbalance in the regulation and expression of Th1 and Th2 cytokines towards a Th1 thought to be protective against cancer. A shift in the balance of the Th1/Th2 response may play a role in aetiology of LNs as suggested by Holly et al. 8 This hypothesis is also supported by recent findings that genetic variation in two key genes of Th2 pathway (IL-10, IL-4) could be associated with NHL.
The associations with gastroenteritis contracted when travelling in Africa or Asia have not been reported yet. Holly et al. 4 did not find any association with foreign travel or contact with persons coming back from Africa. Becker et al. 5 reported no association between malaria and NHL whereas Tavani et al. In conclusion, the present study showed no association between LNs and history of infectious disease except for the expected relationship between Hodgkin's lymphoma and mononucleosis. The inverse trend evidenced with influenza immunization, already described in a large previous study, deserves further investigation. 
